AstraZeneca vaccine benefits 'outweigh' risk of blood clots, say health officials

AstraZeneca vaccine benefits 'outweigh' risk of blood clots, say health officials

File picture: PA

The Health Products Regulatory Authority (HPRA) has been notified of approximately 2,800 reports of suspected side effects associated with the AstraZeneca vaccine.

In a statement, the HPRA said that of 204,270 Astrazeneca doses administered, there were 18 reports describing "blood clots or events possibly associated with blood clots."

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited